Preliminary Scientific Program
Program information is preliminary and subject to change.
Sunday, March 21, 2027
WORKSHOPS
8:30 AM–12:30 PM
Scott M. Hammer Workshop for New Researchers and Trainees
Moderators
Katharine J. Bar, University of Pennsylvania, Philadelphia, PA, USA
Raphael J. Landovitz, University of California Los Angeles, Los Angeles, CA, USA
Virology: The Envelope and You—Perfect Together
Clare Jolly, Queen Mary University of London, London, UK
Immunology of Cure: Where We Are and Where We’re Going
Rachel Rutishauser, University of California San Francisco, San Francisco, CA, USA
HIV Treatment: Innovations and New Horizons
Rajesh T. Gandhi, Harvard University, Cambridge, MA, USA
Prevention: The Art and Promise of an Expanding Toolbox—Successes and Failures
Hyman M. Scott, University of California San Francisco, San Francisco, CA, USA
Scientists on the Frontlines of Disinformation: What Can We Do?
Sharon L. Hillier, University of Pittsburgh, Pittsburgh, PA, USA
2:00 PM–4:00 PM
Clinical Trial Design and Analysis Workshop
Moderators
Ruanne Barnabas, Massachusetts General Hospital, Boston, MA, USA
Richard E. Chaisson, The Johns Hopkins University, Baltimore, MD, USA
DOOR and Net Benefit With Noninferiority Trials
Patrick Phillips, University of San Francisco, San Francisco, CA, USA
Dynamic Borrowing and Use of Real-World Data
Shu Q. Yang, Kaiser Permanente Northern California, Oakland, CA, USA
Simulated Trials Using EPIC or Electronic Medical Records
Laura B. Balzer, University of California Berkeley, Berkeley, CA, USA
Frontiers in Laboratory Sciences
Moderators
Ya-Chi Ho, Yale University, New Haven, CT, USA
Afam A. Okoye, Oregon Health and Science University, Portland, OR, USA
From Structure to Function: The Power of AI
Joe Grove, University of Glasgow, Glasgow, UK
From Structure to Cell Biology: The Power of Cryo-ET
Elizabeth Villa, University of California San Diego, San Diego, CA, USA
In Vitro Engineering: Human Immune Organoids
Catherine Blish, Stanford University, Stanford, CA, USA
In Vivo Engineering: Lipid Nanoparticle Delivery
Gaurav Sahay, Oregon Health and Science University, Portland, OR, USA
Contemporary Issues in Clinical Management: A Case-Based Workshop
Moderators
Wendy S. Armstrong, University of Colorado Denver, Denver, CO, USA
Sanjay Bhagani, Royal Free Hospital, London, UK
Panelists
Panelists to be announced.
OPENING SESSION
5:00 PM–7:00 PM
Bernard Fields Lecture
From Observation to Discovery to Intervention: Broadly Neutralizing Antibodies Against HIV
Alexandra Trkola, University of Zurich, Zurich, Switzerland
The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.
Martin Delaney Presentation
No One Is Expendable: Transgender Rights Are Human Rights and Advocate Is a Noun and a Verb
Tori Cooper, Human Rights Campaign, Atlanta, GA, USA
The Martin Delaney Presentation honors the pioneering HIV/AIDS activist Martin Delaney and recognizes the important contributions of community advocacy and engagement to HIV research.
N’Galy-Mann Lecture
HIV: The Unfinished Epidemic in an Increasingly Unequal Society
Pedro E. Cahn, Fundación Huésped, Buenos Aires, Argentina
The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.
Monday, March 22, 2027
PLENARY SESSION
8:30 AM–9:30 AM
ART Landscape: Past, Present, and Future
Gail V. Matthews, University of New South Wales Sydney, Sydney, Australia
Pediatric HIV, Pediatric Cure, and Vertical Transmission
Philip J.R. Goulder, University of Oxford, Oxford, UK
ORAL ABSTRACT SESSIONS
10:00 AM–12:00 PM
Session details to be announced.
THEMED DISCUSSION SESSIONS
1:30 PM–2:30 PM
Session details to be announced.
POSTER SESSIONS
2:30 PM–4:00 PM
Session details to be announced.
SYMPOSIUM SESSIONS
4:00 PM–5:30 PM
Env Biology and Its Translational Impact
Moderator
Moderator to be announced.
Basic Mechanisms of HIV-1 Env Refolding During Entry
Walter Mothes, Yale University, New Haven, CT, USA
Env Evolution: Escape From Neutralizing Antibodies
Theodora Hatziioannou, Rockefeller University, New York, NY, USA
HIV-1 Env Diversity and Vaccine Design
Kshitij G. Wagh, Duke Human Vaccine Institute, Durham, NC, USA
Low-Level Viremia: Small Signals, Big Questions
Moderator
Jonathan Z. Li, Brigham and Women’s Hospital, Boston, MA, USA
Mechanisms of HIV Persistence: From Residual to Nonsuppressible Viremia
Francesco R. Simonetti, The Johns Hopkins University, Baltimore, MD, USA
Making Sense of Low-Level Viremia: A Clinical and Pharmacologic Approach
Ethel D. Weld, The Johns Hopkins University, Baltimore, MD, USA
When Does Detectable Matter During Pregnancy and Breastfeeding?
Philippe Van de Perre, Université de Montpellier, Montpellier, France
HIV and Substance Use
Moderator
Steven J. Shoptaw, University of California Los Angeles, Los Angeles, CA, USA
Epidemiology of the Substance Use and HIV Syndemics
Anna Deryabina, Columbia University, New York, NY, USA
Innovations in Substance Use Interventions With HIV Treatment and Prevention
Hansel E. Tookes, University of Miami, Miami, FL, USA
Flipping the Delivery Model: Bringing Integrated HIV and Addiction Services to Where People Live
Sandra A. Springer, Yale University, New Haven, CT, USA
Tuesday, March 23, 2027
PLENARY SESSION
8:30 AM–9:30 AM
Mission Possible? Taking Implementation Science to Scale
Kenneth Ngure, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Understanding Untreated and Treated Central Nervous System HIV: A Personal View, 1985–2027
Richard Price, University of San Francisco, San Francisco, CA, USA
ORAL ABSTRACT SESSIONS
10:00 AM–12:00 PM
Session details to be announced.
THEMED DISCUSSION SESSIONS
1:30 PM–2:30 PM
Session details to be announced.
POSTER SESSIONS
2:30 PM–4:00 PM
Session details to be announced.
SYMPOSIUM SESSIONS
4:00 PM–5:30 PM
Engineering the Immune Response: Novel Immunotherapy Approaches
Moderator
Susan Pereira Ribeiro, Emory University, Atlanta, GA, USA
HIV-Specific B-Cell Engineering
Paula M. Cannon, University of Southern California, Los Angeles, CA, USA
Genetic Delivery of IgG Therapeutics for Preventing and Treating HIV-1 Infection
Mauricio A. Martins, University of Florida, Gainesville, FL, USA
Immune Modulators
Mirko Paiardini, Emory University, Atlanta, GA, USA
Mortality Among of People With HIV
Moderator
Moderator to be announced.
Evolution of Mortality Among Adults With HIV: Interventions to Prevent Mortality
Nathan Ford, World Health Organization, Geneva, Switzerland
Evolution of Mortality Among Children With HIV
Saaed Ahmed, Baylor College of Medicine Children’s Foundation, Lilongwe, Malawi
Thinking Critically About Interventions to Reduce Mortality in People With HIV
Maureen Syowai, ICAP at Columbia University, New York, NY, USA
Untying the Knot: Hepatitis B in the Care of Persons With HIV
Moderator
Debika Bhattacharya, University of California Los Angeles, Los Angeles, CA, USA
Hepatitis B: The Quest to Cure
Norah A. Terrault, University of Southern California, Los Angeles, CA, USA
Double Trouble: Tackling HDV in Persons With Hepatitis B
Pietro Lampertico, Universita degli Studi di Milano, Milan, Italy
Untying the Knot: HBV Care in Persons With HIV
Claudia A. Hawkins, Northwestern University, Chicago, IL, USA
Wednesday, March 24, 2027
PLENARY SESSION
8:30 AM–9:30 AM
At Arm’s Length: Vaccine Preventable Conditions Among People With HIV
Demetre C. Daskalakis, Callen-Lorde Community Health Center, New York, NY, USA
Cancer and HIV: From Early Warnings to Emerging Frontiers
Ramya Ramaswami, National Cancer Institute, Bethesda, MD, USA
ORAL ABSTRACT SESSIONS
10:00 AM–12:00 PM
Session details to be announced.
THEMED DISCUSSION SESSIONS
1:30 PM–2:30 PM
Session details to be announced.
POSTER SESSIONS
2:30 PM–4:00 PM
Session details to be announced.
SYMPOSIUM SESSIONS
4:00 PM–5:30 PM
Out of the Box: Early Translational Reservoir Reduction and Cure Strategies
Moderator
Christian Gaebler, Charité – Universitätsmedizin Berlin, Berlin, Germany
What Does It Take to Cure HIV? Lessons From Allogenic Stem Cell Transplantation and CCR5 Blockade
Javier Martinez-Picado, IrsiCaixa, Badalona, Spain
Humanized Mouse Models: Immunotherapeutic Approaches for HIV Reservoir Reduction and Control
Priti Kumar, Yale University, New Haven, CT, USA
DIPs, TIPs, and Their Potential as Novel Therapeutics
Leor Weinberger, University of Miami Miller, Miami, FL, USA
Hot Takes on the Clinical Highlights From CROI 2027
Moderators
Judith S. Currier, University of California Los Angeles, Los Angeles, CA, USA
Rajesh T. Gandhi, Harvard University, Cambridge, MA, USA
Panelists
Panelists to be announced.
This session will feature a dynamic panel discussion highlighting key clinical research findings presented at CROI 2027. Experts across the full clinical spectrum will discuss the studies they found most impactful, implications for clinical practices, and how these results may shape future research priorities.
Integration of HIV Treatment and Prevention Into Primary Care: A Global Perspective
Moderator
Omar Sued, Pan American Health Organization, Washington, DC, USA
How to Get From Here to There
Miriam Rabkin, Columbia University, New York, NY, USA
Implications of Integrated HIV Care Models for Vulnerable Communities
Baker Bakashaba, AIDS Information Centre – Uganda, Kampala, Uganda
Models of Implementation
Sindy Nana Matse, Eswatini National AIDS Programme, Mbabane, Eswatini